In order to gather both qualitative and quantitative insights, supply-side and demand-side stakeholders were interviewed during the primary research process. CEOs, VPs of Product Development, heads of regulatory affairs, directors of quality control, and commercial directors from companies that produce forskolin extract, dietary supplement brands, contract manufacturers, and raw material suppliers were examples of supply-side sources. Retail buyers from pharmacies and health food stores, category managers of e-commerce platforms, nutrition advisors at fitness centers, registered dietitians, sports nutritionists, and procurement leads from wellness retail chains and nutraceutical distributors were examples of demand-side suppliers. In addition to confirming product pipeline timelines and gathering information on clinical adoption patterns, pricing strategies, and distribution channel dynamics, primary research validated market segmentation across product types (root extract, leaf extract, seed extract), applications (weight management, cardiovascular health, immune support, anti-inflammatory, antioxidant), forms (capsules, tablets, powder, liquid extract), sales channels (online stores, health food stores, pharmacies, fitness centers), and target audiences (athletes).
Primary Respondent Breakdown:
By Designation: C-level Primaries (28%), Director Level (32%), Others (40%)
By Region: North America (32%), Europe (30%), Asia-Pacific (28%), Rest of World (10%)
Global market valuation was derived through revenue mapping and consumption volume analysis. The methodology included:
Identification of 50+ key manufacturers and brands across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa
Product mapping across root extract, leaf extract, and seed extract categories, with concentration analysis of active forskolin content (10%, 20%, 40% standardized extracts)
Analysis of reported and modeled annual revenues specific to Forskolin product portfolios across weight management, cardiovascular health, immune support, anti-inflammatory, and antioxidant applications
Coverage of manufacturers representing 75-80% of global market share in 2024
Extrapolation using bottom-up (consumption volume × ASP by country/region) and top-down (manufacturer revenue validation) approaches to derive segment-specific valuations across capsules, tablets, powder, and liquid extract forms, with additional validation through sales channel analysis (online stores, health food stores, pharmacies, fitness centers) and target audience segmentation (fitness enthusiasts, weight loss seekers, health-conscious consumers, athletes)